A system for diagnosing and treating children's brain diseases using advanced technology
Jiangsu Provincial Hospital of Traditional Chinese Medicine
This study is testing a new system that uses advanced technology to help doctors diagnose and treat different brain diseases in children, like ADHD and autism, by combining ideas from both Chinese and Western medicine.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 2 Years to 18 Years |
| Sex | All |
| Sponsor | Affiliated Hospital of Nanjing University of Chinese Medicine Academic / other |
| Locations | 1 site (Nanjing) |
| Trial ID | NCT06848959 on ClinicalTrials.gov |
What this trial studies
This study aims to develop a comprehensive system that utilizes knowledge graphs and large model technology to assist in the diagnosis and treatment of various childhood brain diseases, including cerebral palsy, mental retardation, Tourette's syndrome, ADHD, and autism spectrum disorders. The approach combines elements of both Chinese and Western medicine to create a prevention and popularization system, as well as an assisted decision-making tool and a follow-up tracking system for patients. The study is observational and does not involve any direct interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with cerebral palsy, mental retardation, Tourette's syndrome, ADHD, or autism spectrum disorders.
Not a fit: Patients with other major mental illnesses or organic diseases, such as schizophrenia or congenital heart disease, may not benefit from this study.
Why it matters
Potential benefit: If successful, this system could significantly improve the diagnosis and management of childhood brain diseases, leading to better patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies utilizing technology for diagnosis and treatment in pediatric populations have shown promise, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. meet diagnostic criteria for CP ID TD ADHD ASD; 2. gender is not limited; Exclusion Criteria: * 1\. CP ID TD ASD due to chorea hepatomegaly hearing abnormality and pharmacogenetic factors; * 2\. Children with other major mental illnesses (e.g. schizophrenia) or organic diseases (e.g. congenital heart disease);
Where this trial is running
Nanjing
- Jiangsu Provincial Hospital of Traditional Chinese Medicine — Nanjing, China (Recruiting)
Study contacts
- Study coordinator: Yun Liu PhD
- Email: 20200413@njucm.edu.cn
- Phone: +86 13023876996
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.